Sunrise Medical Laboratories, Inc. Sustainability Profile
Sunrise Medical Laboratories, Inc., a prominent name in the clinical laboratory industry, is headquartered in the United States. Founded in 1993, the company has established itself as a leader in providing comprehensive laboratory testing services across various operational regions, including the Northeast and Midwest. Specialising in a wide array of diagnostic tests, Sunrise Medical Laboratories offers unique services such as advanced molecular diagnostics and toxicology testing, setting them apart in a competitive market. Their commitment to quality and innovation has earned them a strong market position, recognised for their rapid turnaround times and exceptional customer service. With a focus on enhancing patient care, Sunrise Medical Laboratories continues to achieve notable milestones in the healthcare sector.
DitchCarbon Score
How does Sunrise Medical Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunrise Medical Laboratories, Inc.'s score of 66 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sunrise Medical Laboratories, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Sonic Healthcare Limited, which may influence its climate commitments and reporting practices. As part of its corporate family, Sunrise Medical Laboratories inherits climate-related initiatives and performance metrics from Sonic Healthcare Limited. However, there are no documented reduction targets or specific climate pledges available for Sunrise Medical Laboratories at this time. The absence of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for Sunrise Medical Laboratories to establish clear emissions reduction targets and commitments to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 8,124,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 59,156,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Sunrise Medical Laboratories, Inc.'s Industry?
How Carbon Intensive is Sunrise Medical Laboratories, Inc.'s Location?
Sunrise Medical Laboratories, Inc.'s Scope 3 Categories Breakdown
Sunrise Medical Laboratories, Inc.'s Scope 3 emissions, which increased by 13% last year and increased by approximately 1% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 43% of Scope 3 emissions.
Top Scope 3 Categories
Sunrise Medical Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sunrise Medical Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
